Trojan horse transit contributes to blood-brain barrier crossing of a eukaryotic pathogen

mBio

Volumn 8, Issue 1, 2017, Pages

  Santiago Tirado, Felipe H ^a   Onken, Michael D ^a   Cooper, John A ^a   Klein, Robyn S ^a   Doering, Tamara L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD BRAIN BARRIER; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FLOW CYTOMETRY; FUNGUS MUTANT; HORSE; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; NONHUMAN; PHAGOCYTE; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TROJAN HORSE; BIOLOGICAL MODEL; IMMUNE EVASION; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; THEORETICAL MODEL;

BLOOD-BRAIN BARRIER; CRYPTOCOCCUS NEOFORMANS; HUMANS; IMMUNE EVASION; MODELS, BIOLOGICAL; MODELS, THEORETICAL; PHAGOCYTES;

EID: 85014769034     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02183-16     Document Type: Article

References (66)

1. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. 2012. Hidden killers: human fungal infections. Sci Transl Med 4:165rv13. https://doi.org/10.1126/scitranslmed.3004404.
2. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525-530. https://doi.org/10.1097/QAD.0b013e328322ffac.
3. Fox DS, Djordjevic JT, Sorrell TC. 2011. Signaling cascades and enzymes as cryptococcus virulence factors, p 217-234. In Heitman J, Kozel TR, Kwon-Chung KJ, Perfect J, Casadevall A (ed), Cryptococcus: from human pathogen to model yeast. ASM Press, Washington, DC.
4. Srikanta D, Santiago-Tirado FH, Doering TL. 2014. Cryptococcus neoformans: historical curiosity to modern pathogen. Yeast 31:47-60. https://doi.org/10.1002/yea.2997.
5. Serlin Y, Shelef I, Knyazer B, Friedman A. 2015. Anatomy and physiology of the blood-brain barrier. Semin Cell Dev Biol 38:2-6. https://doi.org/10.1016/j.semcdb.2015.01.002.
6. Chang YC, Stins MF, McCaffery MJ, Miller GF, Pare DR, Dam T, Paul-Satyaseela M, Kim KS, Kwon-Chung KJ, Paul-Satyasee M. 2004. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun 72:4985-4995. https://doi.org/10.1128/IAI.72.9.4985-4995.2004.
7. Huang SH, Long M, Wu CH, Kwon-Chung KJ, Chang YC, Chi F, Lee S, Jong A. 2011. Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells is mediated through the lipid rafts-endocytic pathway via the dual specificity tyrosine phosphorylation-regulated kinase 3 (DYRK3). J Biol Chem 286:34761-34769. https://doi.org/10.1074/jbc.M111.219378.
8. Jong A, Wu CH, Shackleford GM, Kwon-Chung KJ, Chang YC, Chen HM, Ouyang Y, Huang SH. 2008. Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell Microbiol 10:1313-1326. https://doi.org/10.1111/j.1462-5822.2008.01128.x.
9. Maruvada R, Zhu L, Pearce D, Zheng Y, Perfect J, Kwon-Chung KJ, Kim KS. 2012. Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier. Cell Microbiol 14: 1544-1553. https://doi.org/10.1111/j.1462-5822.2012.01819.x.
10. Chen SH, Stins MF, Huang SH, Chen YH, Kwon-Chung KJ, Chang Y, Kim KS, Suzuki K, Jong AY. 2003. Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol 52:961-970. https://doi.org/10.1099/jmm.0.05230-0.
11. Olszewski MA, Noverr MC, Chen GH, Toews GB, Cox GM, Perfect JR, Huffnagle GB. 2004. Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol 164:1761-1771. https://doi.org/10.1016/S0002-9440(10)63734-0.
12. Shi M, Li SS, Zheng C, Jones GJ, Kim KS, Zhou H, Kubes P, Mody CH. 2010. Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest 120:1683-1693. https://doi.org/10.1172/JCI41963.
13. Vu K, Eigenheer RA, Phinney BS, Gelli A. 2013. Cryptococcus neoformans promotes its transmigration into the central nervous system by inducing molecular and cellular changes in brain endothelial cells. Infect Immun 81:3139-3147. https://doi.org/10.1128/IAI.00554-13.
14. Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F, Dromer F. 2009. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 77:120-127. https://doi.org/10.1128/IAI.01065-08.
15. Kechichian TB, Shea J, Del Poeta M. 2007. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. Infect Immun 75:4792-4798. https://doi.org/10.1128/IAI.00587-07.
16. Santangelo R, Zoellner H, Sorrell T, Wilson C, Donald C, Djordjevic J, Shounan Y, Wright L. 2004. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect Immun 72:2229-2239. https://doi.org/10.1128/IAI.72.4.2229-2239.2004.
17. Sorrell TC, Juillard PG, Djordjevic JT, Kaufman-Francis K, Dietmann A, Milonig A, Combes V, Grau GE. 2016. Cryptococcal transmigration across a model brain blood-barrier: evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265. Microbes Infect 18:57-67. https://doi.org/10.1016/j.micinf.2015.08.017.
18. Chretien F, Lortholary O, Kansau I, Neuville S, Gray F, Dromer F. 2002. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis 186:522-530. https://doi.org/10.1086/341564.
19. Nicola AM, Robertson EJ, Albuquerque P, Derengowski Lda S, Casadevall A. 2011. Nonlytic exocytosis of Cryptococcus neoformans from macrophages occurs in vivo and is influenced by phagosomal pH. mBio 2:e00167-11. https://doi.org/10.1128/mBio.00167-11.
20. Sabiiti W, May RC. 2012. Capsule independent uptake of the fungal pathogen Cryptococcus neoformans into brain microvascular endothelial cells. PLoS One 7:e35455. https://doi.org/10.1371/journal.pone.0035455.
21. Vu K, Weksler B, Romero I, Couraud PO, Gelli A. 2009. Immortalized human brain endothelial cell line HCMEC/D3 as a model of the bloodbrain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans. Eukaryot Cell 8:1803-1807. https://doi.org/10.1128/EC.00240-09.
22. Weksler B, Romero IA, Couraud PO. 2013. The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 10:16. https://doi.org/10.1186/2045-8118-10-16.
23. Daniels BP, Cruz-Orengo L, Pasieka TJ, Couraud PO, Romero IA, Weksler B, Cooper JA, Doering TL, Klein RS. 2013. Immortalized human cerebral microvascular endothelial cells maintain the properties of primary cells in an in vitro model of immune migration across the blood brain barrier. J Neurosci Methods 212:173-179. https://doi.org/10.1016/j.jneumeth.2012.10.001.
24. Mora DJ, Fortunato LR, Andrade-Silva LE, Ferreira-Paim K, Rocha IH, Vasconcelos RR, Silva-Teixeira DN, Nascentes GA, Silva-Vergara ML. 2015. Cytokine profiles at admission can be related to outcome in AIDS patients with cryptococcal meningitis. PLoS One 10:e0120297. https://doi.org/10.1371/journal.pone.0120297.
25. Panackal AA, Wuest SC, Lin YC, Wu T, Zhang N, Kosa P, Komori M, Blake A, Browne SK, Rosen LB, Hagen F, Meis J, Levitz SM, Quezado M, Hammoud D, Bennett JE, Bielekova B, Williamson PR. 2015. Paradoxical immune responses in non-HIV cryptococcal meningitis. PLoS Pathog 11:e1004884. https://doi.org/10.1371/journal.ppat.1004884.
26. Boulware DR, von Hohenberg M, Rolfes MA, Bahr NC, Rhein J, Akam-purira A, Williams DA, Taseera K, Schutz C, McDonald T, Muzoora C, Meintjes G, Meya DB, Nielsen K, Huppler Hullsiek K. 2016. Human immune response varies by the degree of relative cryptococcal antigen shedding. Open Forum Infect Dis 3:ofv194. https://doi.org/10.1093/ofid/ofv194.
27. He W, Casadevall A, Lee SC, Goldman DL. 2003. Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis. Infect Immun 71:930-936. https://doi.org/10.1128/IAI.71.2.930-936.2003.
28. Kawakami K, Kinjo Y, Uezu K, Yara S, Miyagi K, Koguchi Y, Nakayama T, Taniguchi M, Saito A. 2001. Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J Immunol 167:6525-6532. https://doi.org/10.4049/jimmunol.167.11.6525.
29. Kozel TR, Pfrommer GS, Redelman D. 1987. Activated neutrophils exhibit enhanced phagocytosis of Cryptococcus neoformans opsonized with normal human serum. Clin Exp Immunol 70:238-246.
30. Dong ZM, Murphy JW. 1997. Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect Immun 65:557-563.
31. Guillot L, Carroll SF, Homer R, Qureshi ST. 2008. Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection. Infect Immun 76:4745-4756. https://doi.org/10.1128/IAI.00341-08.
32. Leopold Wager CM, Hole CR, Wozniak KL, Wormley FL, Jr. 2016. Cryptococcus and phagocytes: complex interactions that influence disease outcome. Front Microbiol 7:105. https://doi.org/10.3389/fmicb.2016.00105.
33. Liu TB, Kim JC, Wang Y, Toffaletti DL, Eugenin E, Perfect JR, Kim KJ, Xue C. 2013. Brain inositol is a novel stimulator for promoting Cryptococcus penetration of the blood-brain barrier. PLoS Pathog 9:e1003247. https://doi.org/10.1371/journal.ppat.1003247.
34. Wozniak KL, Ravi S, Macias S, Young ML, Olszewski MA, Steele C, Wormley FL. 2009. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS One 4:e6854. https://doi.org/10.1371/journal.pone.0006854.
35. Sionov E, Mayer-Barber KD, Chang YC, Kauffman KD, Eckhaus MA, Salazar AM, Barber DL, Kwon-Chung KJ. 2015. Type I IFN induction via poly-ICLC protects mice against cryptococcosis. PLoS Pathog 11:e1005040. https://doi.org/10.1371/journal.ppat.1005040.
36. Daniels BP, Klein RS. 2015. Knocking on closed doors: host interferons dynamically regulate blood-brain barrier function during viral infections of the central nervous system. PLoS Pathog 11:e1005096. https://doi.org/10.1371/journal.ppat.1005096.
37. Rochfort KD, Cummins PM. 2015. The blood-brain barrier endothelium: a target for pro-inflammatory cytokines. Biochem Soc Trans 43:702-706. https://doi.org/10.1042/BST20140319.
38. Chang YC, Jong A, Huang S, Zerfas P, Kwon-Chung KJ. 2006. CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans. Infect Immun 74:3930-3938. https://doi.org/10.1128/IAI.00089-06.
39. Singh A, Panting RJ, Varma A, Saijo T, Waldron KJ, Jong A, Ngamskul-rungroj P, Chang YC, Rutherford JC, Kwon-Chung KJ. 2013. Factors required for activation of urease as a virulence determinant in Cryptococcus neoformans. mBio 4:e00220-13. https://doi.org/10.1128/mBio.00220-13.
40. Join-Lambert OF, Ezine S, Le Monnier A, Jaubert F, Okabe M, Berche P, Kayal S. 2005. Listeria monocytogenes-infected bone marrow myeloid cells promote bacterial invasion of the central nervous system. Cell Microbiol 7:167-180. https://doi.org/10.1111/j.1462-5822.2004.00444.x.
41. Lachenmaier SM, Deli MA, Meissner M, Liesenfeld O. 2011. Intracellular transport of Toxoplasma gondii through the blood-brain barrier. J Neuroimmunol 232:119-130. https://doi.org/10.1016/j.jneuroim.2010.10.029.
42. Neal JW. 2014. Flaviviruses are neurotropic, but how do they invade the CNS? J Infect 69:203-215. https://doi.org/10.1016/j.jinf.2014.05.010.
43. Nguyen L, Pieters J. 2005. The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages. Trends Cell Biol 15:269-276. https://doi.org/10.1016/j.tcb.2005.03.009.
44. Zlotkin A, Chilmonczyk S, Eyngor M, Hurvitz A, Ghittino C, Eldar A. 2003. Trojan horse effect: phagocyte-mediated Streptococcus iniae infection of fish. Infect Immun 71:2318-2325. https://doi.org/10.1128/IAI.71.5.2318-2325.2003.
45. O’Neill AM, Thurston TL, Holden DW. 2016. Cytosolic replication of group A streptococcus in human macrophages. mBio 7:e00020-16. https://doi.org/10.1128/mBio.00020-16.
46. Tse JR, Engler AJ. 2010. Preparation of hydrogel substrates with tunable mechanical properties. Curr Protoc Cell Biol 47:10.16:10.16.1-10.16.16. https://doi.org/10.1002/0471143030.cb1016s47.
47. Muller WA. 2015. The regulation of transendothelial migration: new knowledge and new questions. Cardiovasc Res 107:310-320. https://doi.org/10.1093/cvr/cvv145.
48. García-Rodas R, Zaragoza O. 2012. Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans. FEMS Immunol Med Microbiol 64:147-161. https://doi.org/10.1111/j.1574-695X.2011.00871.x.
49. Ma H, Croudace JE, Lammas DA, May RC. 2007. Direct cell-to-cell spread of a pathogenic yeast. BMC Immunol 8:15. https://doi.org/10.1186/1471-2172-8-15.
50. Alvarez M, Casadevall A. 2007. Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macro-phages. BMC Immunol 8:16. https://doi.org/10.1186/1471-2172-8-16.
51. Barchiesi F, Cogliati M, Esposto MC, Spreghini E, Schimizzi AM, Wickes BL, Scalise G, Viviani MA. 2005. Comparative analysis of pathogenicity of Cryptococcus neoformans serotypes A, D and AD in murine cryptococcosis. J Infect 51:10-16. https://doi.org/10.1016/j.jinf.2004.07.013.
52. Ngamskulrungroj P, Chang Y, Sionov E, Kwon-Chung KJ. 2012. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model. mBio 3:e00103-12. https://doi.org/10.1128/mBio.00103-12.
53. Charlier C, Chretien F, Baudrimont M, Mordelet E, Lortholary O, Dromer F. 2005. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 166:421-432. https://doi.org/10.1016/S0002-9440(10)62265-1.
54. Sridhar S, Ahluwalia M, Brummer E, Stevens DA. 2000. Characterization of an anticryptococcal protein isolated from human serum. Infect Immun 68:3787-3791. http://www.ncbi.nlm.nih.gov/pubmed/10816550.
55. Zhang M, Sun D, Liu G, Wu H, Zhou H, Shi M. 2016. Real-time in vivo imaging reveals the ability of neutrophils to remove Cryptococcus neoformans directly from the brain vasculature. J Leukoc Biol 99:467-473. https://doi.org/10.1189/jlb.4AB0715-281R.
56. Carman CV. 2009. Mechanisms for transcellular diapedesis: probing and pathfinding by “invadosome-like protrusions”. J Cell Sci 122:3025-3035. https://doi.org/10.1242/jcs.047522.
57. Bojarczuk A, Miller KA, Hotham R, Lewis A, Ogryzko NV, Kamuyango AA, Frost H, Gibson RH, Stillman E, May RC, Renshaw SA, Johnston SA. 2016. Cryptococcus neoformans intracellular proliferation and capsule size determines early macrophage control of infection. Sci Rep 6:21489. https://doi.org/10.1038/srep21489.
58. Jong A, Wu CH, Gonzales-Gomez I, Kwon-Chung KJ, Chang YC, Tseng HK, Cho WL, Huang SH. 2012. Hyaluronic acid receptor CD44 deficiency is associated with decreased Cryptococcus neoformans brain infection. J Biol Chem 287:15298-15306. https://doi.org/10.1074/jbc.M112.353375.
59. Samantaray S, Correia JN, Garelnabi M, Voelz K, May RC, Hall RA. 2016. Novel cell-based in vitro screen to identify small-molecule inhibitors against intracellular replication of Cryptococcus neoformans in macrophages. Int J Antimicrob Agents 48:69-77. https://doi.org/10.1016/j.ijantimicag.2016.04.018.
60. Konradt C, Ueno N, Christian DA, Delong JH, Pritchard GH, Herz J, Bzik DJ, Koshy AA, McGavern DB, Lodoen MB, Hunter CA. 2016. Endothelial cells are a replicative niche for entry of Toxoplasma gondii to the central nervous system. Nat Microbiol 1:16001. https://doi.org/10.1038/nmicrobiol.2016.1.
61. Santiago-Tirado FH, Peng T, Yang M, Hang HC, Doering TL. 2015. A single protein S-acyl transferase acts through diverse substrates to determine cryptococcal morphology, stress tolerance, and pathogenic outcome. PLoS Pathog 11:e1004908. https://doi.org/10.1371/journal.ppat.1004908.
62. Nielsen K, Cox GM, Wang P, Toffaletti DL, Perfect JR, Heitman J. 2003. Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates. Infect Immun 71:4831-4841. https://doi.org/10.1128/IAI.71.9.4831-4841.2003.
63. Liu OW, Chun CD, Chow ED, Chen C, Madhani HD, Noble SM. 2008. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 135:174-188. https://doi.org/10.1016/j.cell.2008.07.046.
64. Tong AH, Evangelista M, Parsons AB, Xu H, Bader GD, Pagé N, Robinson M, Raghibizadeh S, Hogue CW, Bussey H, Andrews B, Tyers M, Boone C. 2001. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 294:2364-2368. https://doi.org/10.1126/science.1065810.
65. Biemans EA, Jäkel L, de Waal RM, Kuiperij HB, Verbeek MM. 2016. Limitations of the hCMEC/D3 cell line as a model for Abeta clearance by the human blood-brain barrier. J Neurosci Res https://doi.org/10.1002/jnr.23964.
66. Onken MD, Mooren OL, Mukherjee S, Shahan ST, Li J, Cooper JA. 2014. Endothelial monolayers and transendothelial migration depend on mechanical properties of the substrate. Cytoskeleton (Hoboken) 71: 695-706. https://doi.org/10.1002/cm.21203.